Strouse John

Strouse John, a sole proprietorship based in Durham, North Carolina, provides medical expert witness services and case review analysis for the Vaccine Injury Compensation Program (VICP) and Countermeasures Injury Compensation Program (CICP) as a prime contractor on small-business-set-aside and full-and-open BPA calls issued by the Department of Health and Human Services Health Resources and Services Administration (HRSA).

Strouse John's footprint is concentrated almost entirely within a single customer and mission area. HRSA accounts for 43 of 45 awards (95% of awards) and $8.5 million of the $8.5 million combined potential value; the Department of Justice Civil Division holds two awards worth $8 thousand. The vendor sits on four active BPAs with HRSA: Blanket Purchase Agreement 75R60221A00095 (18 task orders, $90 thousand combined potential value), Blanket Purchase Agreement HHSH250201400011B (10 task orders, $21 thousand combined potential value), Blanket Purchase Agreement 75R60219A00111 (8 task orders, $10 thousand combined potential value), and a newly awarded Blanket Purchase Agreement 75R60226A00046 (1 task order, $38 thousand combined potential value). On August 31, 2026, HRSA established a new single-award $7.5 million BPA with a ceiling and completion date through August 30, 2031, with the first call valued at $37,500 issued on September 2, 2026.

Strouse John's work centers on medical record analysis, clinical evidence research, and expert consultation supporting HRSA's adjudication of vaccine-injury compensation claims. Representative recent awards include the $37,500 September 2026 BPA call for medical expert witness services under the new vehicle, a $7,500 March 2026 task order for VICP and CICP case review (total small business set-aside), and a $17,000 March 2025 call for medical case reviewer services (total small business set-aside). Earlier work includes five BPA calls between July 2024 and August 2024 ranging from $3,750 to $7,500, supporting individual VICP case evaluations. Pricing across the portfolio is firm fixed price, with individual task orders historically ranging from $1,500 to $17,000.

Activity has been modest and variable over the past five years — five awards in 2022, three in 2023, four in 2024, two in 2025, and four through September 2026 — reflecting small task-order work. However, the August 2026 $7.5 million BPA represents a significant expansion of the existing ceiling and extends Strouse John's contract vehicle through mid-2031. Only three awards face ultimate completion within the next twenty-four months (combined potential value $53 thousand), with the remainder of the new BPA runway extending five years beyond the near-term recompete window. Strouse John operates exclusively as a prime on BPA calls; there is no subcontract footprint in the source data.

We provide health care consulting with a focus on pediatric and adult hematology, clinical research, and public health as well as expert witness.